OpEdNews -
24 Jul 2014 19:59 Global Alliance for TB-Drug Development (TB Alliance) raised hopes of a novel drug regimen to treat both forms of TB--drug sensitive (DS) and multi-drug resistant (MDR)--at the XX International AIDS Conference (AIDS 2014) in Melbourne, offering a new paradigm in TB treatment to treat patients with drugs to which they are sensitive, rather than based on what they are resistant to.
Please to comment